Compare Global X FTSE Southeast Asia ETF (ASEA) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X FTSE Southeast Asia ETF vs Ascendis Pharma A/S — how do they compare? Global X FTSE Southeast Asia ETF trades at $21.47, while Ascendis Pharma A/S trades at $255.5 (market cap $16.67B). The key difference: Global X FTSE Southeast Asia ETF is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASEA | ASND | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $21.53 | $277.18 |
52-Week Low | $16.86 | $189.74 |
Market Cap | — | $16.67B |
Enterprise Value | — | $17.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X FTSE Southeast Asia ETF
ASEA tracks the performance of the largest companies in Southeast Asia. It provides exposure to key emerging markets including Singapore, Indonesia, Thailand, and Malaysia, with a heavy focus on financials like DBS Group and Bank Central Asia.
Read more on ASEA →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
